SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001811764-22-000044
Filing Date
2022-05-12
Accepted
2022-05-12 08:54:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 pnt-424b3andform8xkcombine.htm 424B3 32009
2 point-logoxcolour1.jpg GRAPHIC 17537
  Complete submission text file 0001811764-22-000044.txt   57319
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22915907
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences